Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, June 29, 2021

Post-stroke Anxiety Analysis via Machine Learning Methods

Post stroke anxiety is so fucking easy to explain. NO PROTOCOLS LEADING TO 100% RECOVERY. Solve that problem you fucking idiots, you don't need to analyze why anxiety exists, prevent it from occurring. PROTOCOLS NEEDED!

Post-stroke Anxiety Analysis via Machine Learning Methods

Jirui Wang1, Defeng Zhao2, Meiqing Lin1, Xinyu Huang3 and Xiuli Shang1*
  • 1Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China
  • 2The First Clinical Department, China Medical University, Shenyang, China
  • 3Software College, Northeastern University, Shenyang, China

Post-stroke anxiety (PSA) has caused wide public concern in recent years, and the study on risk factors analysis and prediction is still an open issue. With the deepening of the research, machine learning has been widely applied to various scenarios and make great achievements increasingly, which brings new approaches to this field. In this paper, 395 patients with acute ischemic stroke are collected and evaluated by anxiety scales (i.e., HADS-A, HAMA, and SAS), hence the patients are divided into anxiety group and non-anxiety group. Afterward, the results of demographic data and general laboratory examination between the two groups are compared to identify the risk factors with statistical differences accordingly. Then the factors with statistical differences are incorporated into a multivariate logistic regression to obtain risk factors and protective factors of PSA. Statistical analysis shows great differences in gender, age, serious stroke, hypertension, diabetes mellitus, drinking, and HDL-C level between PSA group and non-anxiety group with HADS-A and HAMA evaluation. Meanwhile, as evaluated by SAS scale, gender, serious stroke, hypertension, diabetes mellitus, drinking, and HDL-C level differ in the PSA group and the non-anxiety group. Multivariate logistic regression analysis of HADS-A, HAMA, and SAS scales suggest that hypertension, diabetes mellitus, drinking, high NIHSS score, and low serum HDL-C level are related to PSA. In other words, gender, age, disability, hypertension, diabetes mellitus, HDL-C, and drinking are closely related to anxiety during the acute stage of ischemic stroke. Hypertension, diabetes mellitus, drinking, and disability increased the risk of PSA, and higher serum HDL-C level decreased the risk of PSA. Several machine learning methods are employed to predict PSA according to HADS-A, HAMA, and SAS scores, respectively. The experimental results indicate that random forest outperforms the competitive methods in PSA prediction,(Survivors don't need you to predict anxiety, they need you to prevent it from occurring.) which contributes to early intervention for clinical treatment.

1. Introduction

Stroke is a medical condition in which poor blood flow to the brain results in cell death, associated with high morbidity, high disability, and high mortality across the world (Wolfe, 2000). Notably, approximately 2.5 million new stroke cases annually occur in China and the mortality rate has reached 11.48% (Sun et al., 2013; Chen et al., 2017). Mood problems such as depression, apathy, and distress are commonly reported with post-stroke (Hackett et al., 2014), but anxiety in stroke patients has been relatively neglected both in clinical and research settings, in spite of its ubiquity in the general population (Remes et al., 2016). Post-stroke anxiety (PSA) refers that stroke patients extremely concern about the prognosis status, e.g., recurrence, re-working abilities, the occurrence of fall accidents, and so on (Gilworth et al., 2009). Once stroke onset, anxiety becomes common throughout the acute phase, after months, and even after years (Lincoln et al., 2013). A systematic review and meta-analysis shows that the prevalence of anxiety disorders is 29.3% post-stroke during the first year, with 36.7% in 2 weeks, 24.1% in 2 weeks to 3 months, and 23.8% in 3–12 months (Rafsten et al., 2018). Specifically, Knapp et al. (2020) collect and analyze 53 studies and report 25.5% of stroke patients developed PSA within 1 month of stroke, 23.6% in 1 and 5 months, and 21.5% in 6 months to 1 year. A plethora of studies indicate that PSA significantly influences the living quality (Lincoln et al., 2013), which is associated with the delaying recovery of neurological function (Chun et al., 2018), and the interventions on anxiety disorders have a positive impact on the incidence of both coronary artery disease and stroke (Pérez-Piñar et al., 2017).

Given the significant impact of PSA on patient outcomes, great emphasis has been placed on risk reduction and early detection. However, the pathophysiology of PSA is still unknown and the relevant risk factors are controversial. A systematic review on 18 observational studies with 8,130 patients suggests that pre-stroke depression, stroke severity, early anxiety, and dementia (or cognitive) impairment following stroke are the main predictors of PSA, while the lack of methodological and statistical rigorously affects the validity of predictive models, which indicates future research should focus on testing predictive models on both internal and external samples to ultimately inform future clinical practice (Menlove et al., 2015). Accurate individual patient risk prediction would allow for evaluation and intervention even earlier in the pathologic process. Notably, it is critical to identify risk factors associated with PSA and build models to predict PSA.

With the rapid development of advanced technology, artificial intelligence has been applied extensively in a variety of professions. As an important tool in artificial intelligence field, machine learning (Alpaydin, 2020) has received increasing attention in the last decades, which is widely utilized in medical image processing, autonomous driving, computer vision, and so on. Classic machine learning models such as linear models, decision trees (Kamiński et al., 2018), Bayesian classifiers (Kohavi, 1996), Support Vector Machines (SVM) (Cortes and Vapnik, 1995), neural networks (Müller et al., 2012), Stochastic Gradient Descent (denoted by SGD Classifier) (Zhang, 2004), Multilayer Perceptron (denoted by MLP) (Rumelhart et al., 1986), and random forests (Breiman, 2001) have exhibited certain specific usage, i.e., there are no methods suitable for solving problems at any real-life scenarios. Stochastic gradient descent is an iterative method for optimizing an objective function with suitable smoothness properties, which can be regarded as a stochastic approximation of gradient descent optimization (Saad, 1998). A multilayer perceptron is a class of feedforward artificial neural networks, which consists of at least three layers of nodes: an input layer, a hidden layer, and an output layer. MLP utilizes a supervised learning technique called backpropagation for training, which can distinguish data that is not linearly separable (Hastie et al., 2009). An SVM maps training examples to points in space so as to maximize the width of the gap between the two categories. New examples are then mapped into that same space and predicted to belong to a category based on which side of the gap they fall (Joachims, 1998). Random forest (RF), proposed by Breiman (2001), consists of a set of decision trees, each of which is a decision support tool that uses a tree-like model of decisions and their possible consequences, including chance event outcomes, resource costs, and utility (Kamiński et al., 2018). Random Forest can be used in the prediction of incident delirium (Corradi et al., 2018), malignancy of pulmonary nodules (Mei et al., 2018), survival from large echocardiography, electronic health record datasets (Samad et al., 2019), and so on. The basic thought is to determine the input sample by random sampling, and the sample data obtained will be handed over to each decision tree for judgment, thereby all the results will be voted, and the result with the most votes will be used as the output. Hence, the random forest also has ensemble learning, which can improve the accuracy of the predictive model.

Inspired by such new methods, this study plans to develop proper PSA prediction models using machine learning methods. To the best of our knowledge, this is the first study to apply machine learning to predicting anxiety for post-stroke patients. This work can identify anxiety patients after stroke at an early stage, thus benefits guiding appropriate prevention and treatments to avoid leading to severe outcomes.

The main contributions of this paper are listed as follows:

(1) The main factors of PSA are analyzed in detail by traditional statistical methods between patients with/without PSA, and then all the factors with statistical difference are put into a multivariable logistic regression analysis to study in-depth.

(2) Different anxiety test scales (i.e., HADS-A, HAMA, and SAS) are taken into consideration to evaluate the degree of PSA.

(3) Classic machine learning methods such as decision tree and random forest are employed as predictive models to estimate PSA, and random forest outperforms the competitive approaches.

The rest of this paper is organized as follows. Section 2 introduces the material and methods for clinical data collection. Section 3 gives data analysis and experimental environment for machine learning methods. Section 4 exhibits experimental results of statistical analysis and PSA prediction comparison via different machine learning methods. Section 5 exhibits the discussion on the obtained results. Section 6 summarizes the whole paper and provides concluding remarks.

 

Sunday, June 27, 2021

Applicability of stroke-unit care to low-income and middle-income countries

You can see here that 9 years ago the availability problem was recognized and yet  they totally ignored the massive die off of neurons even if these stroke units are set up.  I got tPA in 90 minutes causing 177 million neurons to die, yet that is miniscule to the 5.4 billion neurons dying during the neuronal cascade of death  in the first week. So while availability is a problem to be solved the bigger problem is being ignored.

Applicability of stroke-unit care to low-income and middle-income countries

PlumX Metrics

Summary

Stroke units have become established as the central component of modern stroke services. However, most stroke-unit trials and service developments have been done in high-income countries, which raises the question of whether such care is relevant and applicable to low-income and middle-income settings. To address this question, we first need to show that stroke units are likely to provide important health gains to populations. Second, we need to identify those components of stroke units that could be important for a low-technology unit, and to learn from examples of stroke units in low-income and middle-income countries. Finally, we need to understand how barriers to the establishment of stroke units could be overcome. Although substantial challenges are present to the development of stroke units more widely across the world, the potential gains from such developments are substantial.
This article is available free of charge.
Simply log in to access the full article, or register for free if you do not yet have a username and password.
 

Saturday, June 26, 2021

Muscle's smallest building blocks disappear after stroke

So how do we rebuild/replace these sarcomeres?

Muscle's smallest building blocks disappear after stroke 

First study to observe this phenomenon in humans

Northwestern University

Research News

After suffering a stroke, patients often are unable to use the arm on their affected side. Sometimes, they end up holding it close to their body, with the elbow flexed.

In a new study, Northwestern University and Shirley Ryan AbilityLab researchers have discovered that, in an attempt to adapt to this impairment, muscles actually lose sarcomeres -- their smallest, most basic building blocks.

Stacked end to end (in series) and side to side (in parallel), sarcomeres make up the length and width of muscle fibers. By imaging biceps muscles with three noninvasive methods, the researchers found that stroke patients had fewer sarcomeres along the length of the muscle fiber, resulting in a shorter overall muscle structure.

The research was published today (June 25) in the Proceedings of the National Academy of Arts and Sciences.

This finding is consistent with the common patient experience of abnormally tight, stiff muscles that resist stretching, and it suggests that changes in the muscle potentially amplify existing issues caused by stroke, which is a brain injury. The team hopes this discovery can help improve rehabilitation techniques to rebuild sarcomeres, ultimately helping to ease muscle tightening and shortening.

"This is the most direct evidence yet that chronic impairments, which place a muscle in a shortened position, are associated with the loss of serial sarcomeres in humans," said Wendy Murray, the study's senior author. "Understanding how muscles adapt following impairments is critical to designing more effective clinical interventions to mitigate such adaptations and to improve function following motor impairments."

Murray is a professor of biomedical engineering at Northwestern's McCormick School of Engineering, a professor of physical medicine and rehabilitation at the Northwestern University Feinberg School of Medicine and research scientist at the Shirley Ryan AbilityLab. The research was completed in collaboration with Julius Dewald, professor of physical therapy and human movement sciences and of physical medicine and rehabilitation at Feinberg, professor of biomedical engineering at McCormick, and research scientist at Shirley Ryan AbilityLab.

First demonstration in humans

Measuring just 1.5 to 4.0 microns in length, sarcomeres comprise two main proteins: actin and myosin. When these proteins work together, they enable a muscle to contract and produce force. Although previous animal studies have found that muscles lose serial sarcomeres after a limb is immobilized in a cast, the phenomenon had never before been demonstrated in humans. In the animal studies, muscles that were shorter because they lost serial sarcomeres also became stiffer.

"There is a classic relationship between force and length," said Amy Adkins, a Ph.D. student in Murray's laboratory and the study's first author. "Given that the whole muscle is composed of these building blocks, losing some of them affects how much force the muscle can generate."

To conduct the study in humans, the researchers combined three non-invasive medical imaging techniques: MRI to measure muscle volume, ultrasound to measure bundles of muscle fibers and two-photon microendoscopy to measure the microscopic sarcomeres.

Imaging opens new possibilities

Combining these technologies at Northwestern and Shirley Ryan AbilityLab, the researchers imaged biceps from seven stroke patients and four healthy participants. Because stroke patients are more affected on one side of their body, the researchers compared imaging from the patients' affected side to their unaffected side as well as to images from the healthy participants.

The researchers found that the stroke patients' affected biceps had less volume, shorter muscle fibers and comparable sarcomere lengths. After combining data across scales, they found that affected biceps had fewer sarcomeres in series compared to the unaffected biceps. The differences between stroke patients' arms were greater than in in healthy participants' arms, indicating that the differences were associated with stroke.

By combining medical imaging to better view muscle structure, the study also establishes that it is possible to study muscle adaptations in sarcomere number in humans. Before two-photon microendoscopy, human studies were limited either to examining dissected tissues in anatomy labs, which give imperfect insight into how muscles adapt to injury and impairment, measuring sarcomere lengths during surgery or from a muscle biopsy, which restricts who can participate in the study.

"In almost every facet of our world, there is an important relationship between how something is put together (its structure) and how it works (its function)," the researchers said. "Part of the reason medical imaging is such a valuable resource and clinical tool is that this is also true for the human body, and imaging gives us an opportunity to measure structure."

###

The study, "Serial sarcomere number is substantially decreased within the paretic biceps brachii in individuals with chronic hemiparetic stroke," was supported by the National Science Foundation (award number DGE-1324585) and the National Institutes of Health (R01HD084009).

 

The Ambibaric Brain: Pathophysiological and Clinical Implications

 No clue.

The Ambibaric Brain: Pathophysiological and Clinical Implications

Originally publishedhttps://doi.org/10.1161/STROKEAHA.120.033492Stroke. 2021;52:e259–e262

We propose a new evolutionary interpretation of the brain’s circulation that has physiological, pathophysiological, and clinical implications. We review the evidence for the concept, discuss clinical implications, and suggest techniques to address outstanding questions. We conclude that the brain circulation contains complementary low-pressure and high-pressure system that must be kept in balance for optimal brain health.

 

Project Big Life Dementia Calculator

 Based on your responses, your risk of being diagnosed with dementia in the next five years is 3%.

Actually I consider it much lower than that.

No easy way to change your answers and see which questions you need to improve upon.


Project Big Life Dementia Calculator

Or you can try this one, much less info provided, doesn't take into account exercise or social connections.

 

 

Dementia Risk Calculator - Medindia

I'm high risk here, which I completely reject.